196 related articles for article (PubMed ID: 27380263)
1. Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide.
Schirle NT; Kinberger GA; Murray HF; Lima WF; Prakash TP; MacRae IJ
J Am Chem Soc; 2016 Jul; 138(28):8694-7. PubMed ID: 27380263
[TBL] [Abstract][Full Text] [Related]
2. Probing the Binding Interactions between Chemically Modified siRNAs and Human Argonaute 2 Using Microsecond Molecular Dynamics Simulations.
Harikrishna S; Pradeepkumar PI
J Chem Inf Model; 2017 Apr; 57(4):883-896. PubMed ID: 28287733
[TBL] [Abstract][Full Text] [Related]
3. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
4. siRNA potency enhancement via chemical modifications of nucleotide bases at the 5'-end of the siRNA guide strand.
Shinohara F; Oashi T; Harumoto T; Nishikawa T; Takayama Y; Miyagi H; Takahashi Y; Nakajima T; Sawada T; Koda Y; Makino A; Sato A; Hamaguchi K; Suzuki M; Yamamoto J; Tomari Y; Saito JI
RNA; 2021 Feb; 27(2):163-173. PubMed ID: 33177188
[TBL] [Abstract][Full Text] [Related]
5. siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2.
Elkayam E; Parmar R; Brown CR; Willoughby JL; Theile CS; Manoharan M; Joshua-Tor L
Nucleic Acids Res; 2017 Apr; 45(6):3528-3536. PubMed ID: 27903888
[TBL] [Abstract][Full Text] [Related]
6. Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs.
Angart PA; Adu-Berchie K; Carlson RJ; Vocelle DB; Chan C; Walton SP
Methods Mol Biol; 2019; 1974():41-56. PubMed ID: 31098994
[TBL] [Abstract][Full Text] [Related]
7. Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties.
Wee LM; Flores-Jasso CF; Salomon WE; Zamore PD
Cell; 2012 Nov; 151(5):1055-67. PubMed ID: 23178124
[TBL] [Abstract][Full Text] [Related]
8. Terminus-free siRNA prepared by photo-crosslinking activated via slicing by Ago2.
Kamiya Y; Iishiba K; Doi T; Tsuda K; Kashida H; Asanuma H
Biomater Sci; 2015 Dec; 3(12):1534-8. PubMed ID: 26526389
[TBL] [Abstract][Full Text] [Related]
9. Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.
Angart PA; Carlson RJ; Adu-Berchie K; Walton SP
Nucleic Acid Ther; 2016 Oct; 26(5):309-317. PubMed ID: 27399870
[TBL] [Abstract][Full Text] [Related]
10. D-Isonucleotide (isoNA) incorporation around cleavage site of passenger strand promotes the vibration of Ago2-PAZ domain and enhances in vitro potency of siRNA.
Huang Y; Tian M; Zhang Y; Sheng G; Chen Z; Ma Y; Chen Y; Peng Y; Zhao YL; Wang Y; Zhang L; Yang Z
Org Biomol Chem; 2015 Nov; 13(44):10825-33. PubMed ID: 26313718
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolically stable 5'-phosphate analogs that support single-stranded siRNA activity.
Prakash TP; Lima WF; Murray HM; Li W; Kinberger GA; Chappell AE; Gaus H; Seth PP; Bhat B; Crooke ST; Swayze EE
Nucleic Acids Res; 2015 Mar; 43(6):2993-3011. PubMed ID: 25753666
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
[TBL] [Abstract][Full Text] [Related]
13. DICER-ARGONAUTE2 complex in continuous fluorogenic assays of RNA interference enzymes.
Bernard MA; Wang L; Tachado SD
PLoS One; 2015; 10(3):e0120614. PubMed ID: 25793518
[TBL] [Abstract][Full Text] [Related]
14. Loading of Argonaute Protein with Small Duplex RNA in Cellular Extracts.
Gagnon KT
Methods Mol Biol; 2016; 1421():53-67. PubMed ID: 26965257
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID.
Kamiya Y; Takeyama Y; Mizuno T; Satoh F; Asanuma H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717920
[TBL] [Abstract][Full Text] [Related]
16. siRNA enrichment in Argonaute 2-depleted Blattella germanica.
Montañés JC; Rojano C; Ylla G; Piulachs MD; Maestro JL
Biochim Biophys Acta Gene Regul Mech; 2021; 1864(6-7):194704. PubMed ID: 33895310
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Control of siRNA Off-Target Effects.
Suter SR; Sheu-Gruttadauria J; Schirle NT; Valenzuela R; Ball-Jones AA; Onizuka K; MacRae IJ; Beal PA
J Am Chem Soc; 2016 Jul; 138(28):8667-9. PubMed ID: 27387838
[TBL] [Abstract][Full Text] [Related]
18. Differences in silencing of mismatched targets by sliced versus diced siRNAs.
Sun G; Wang J; Huang Y; Yuan CW; Zhang K; Hu S; Chen L; Lin RJ; Yen Y; Riggs AD
Nucleic Acids Res; 2018 Jul; 46(13):6806-6822. PubMed ID: 29718312
[TBL] [Abstract][Full Text] [Related]
19. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
Deleavey GF; Frank F; Hassler M; Wisnovsky S; Nagar B; Damha MJ
Nucleic Acid Ther; 2013 Feb; 23(1):81-7. PubMed ID: 23289589
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional analyses reveal the contributions of the C- and N-lobes of Argonaute protein to selectivity of RNA target cleavage.
Dayeh DM; Kruithoff BC; Nakanishi K
J Biol Chem; 2018 Apr; 293(17):6308-6325. PubMed ID: 29519815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
